Eladynos (abaloparatide) | Therapeutic Goods Administration (TGA)

AusPAR

AusPAR for Eladynos [PDF, 461.54 KB]

AusPAR for Eladynos [Word, 402.39 KB]

Attachment: Product information for Eladynos [PDF, 285.96 KB]

Attachment: Product information for Eladynos [Word, 371.01 KB]

Device/Product Name

Eladynos

Active ingredients

Abaloparatide

AusPAR Date

6 November 2024

Published

6 March 2025

Submission Number

PM-2023-05942-1-5

Submission Type

New chemical entity

Decision

Approved